Skorpios Trust
Stoke Therapeutics, Inc. · 10% Owner
Skorpios Trust is listed in filings as 10% Owner at Stoke Therapeutics, Inc.. This profile follows SEC Form 4 activity through Jun 6, 2025, including sale activity. Recent filings connect the profile to Stoke Therapeutics, Inc. (STOK). The current snapshot covers public activity from Sep 23, 2024 to Jun 6, 2025. Reported amounts are shown as $27.2M to $30.6M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $27M1.9M shares | SellSep 19, 2024 | $14.05 | $29.11 | |
| $23M2M shares | SellDec 23, 2024 | $11.50 | $29.11 |